Paweł Golik
- Clinical Biochemistry top 1%
- Molecular Biology top 5%
- RNA and protein synthesis mechanisms 19
- Mitochondrial Function and Pathology 17
- RNA Research and Splicing 17
- RNA modifications and cancer 16
- Fungal and yeast genetics research 15
- Genomics and Phylogenetic Studies 7
- Microbial Metabolic Engineering and Bioproduction 7
- ATP Synthase and ATPases Research 4
- Aging top 5%
- Genetics top 5%
- Cancer Research top 10%
- Co-authors
- Douglas C. WallaceR. I. SukernikMichael D. BrownKirk A. EasleyMartin BrandonAntonel OlckersAndrew G. ClarkEduardo Ruiz‐Pesini
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Nature Communications (1 paper)The EMBO Journal (1 paper)
- Partner nations
- PolandFranceUnited States
In The Last Decade
Paweł Golik
53 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Clinical Biochemistry 303
- Molecular Biology 1.9k
- Aging 40
- Genetics 530
- Cancer Research 167
Countries citing papers authored by Paweł Golik
This map shows the geographic impact of Paweł Golik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Golik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Golik more than expected).
Fields of papers citing papers by Paweł Golik
This network shows the impact of papers produced by Paweł Golik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Golik. The network helps show where Paweł Golik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paweł Golik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 6 | |
| 6 | 2020 | 4 | |
| 7 | 2019 | 3 | |
| 8 | 2015 | 24 | |
| 9 | [Comparison of the biological principles underlying the action of monoclonal antibody (mAb) and decoy receptor anti-VEGF agents--on the example of ranibizumab (anti-VEGF-A mAb) and aflibercept (decoy VEGFR1-2 receptor)]. | 2012 | 3 |
| 10 | 2011 | 19 | |
| 11 | 2011 | 45 | |
| 12 | 2009 | 7 | |
| 13 | 2008 | 14 | |
| 14 | 2008 | 24 | |
| 15 | Mitochondria jako integratory apoptozy | 2006 | 5 |
| 16 | 2006 | 76 | |
| 17 | 2005 | 36 | |
| 18 | Natural selection shaped regional mtDNA variation in humansbreakdown → | 2002 | 790 |
| 19 | Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. | 2002 | 71 |
| 20 | 1997 | 12 |
About Paweł Golik
Paweł Golik is a scholar working on Molecular Biology, Clinical Biochemistry and Cancer Research, having authored 54 papers that have together received 2.5k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (19 papers), Mitochondrial Function and Pathology (17 papers), RNA Research and Splicing (17 papers), RNA modifications and cancer (16 papers), Fungal and yeast genetics research (15 papers), Genomics and Phylogenetic Studies (7 papers), Microbial Metabolic Engineering and Bioproduction (7 papers) and ATP Synthase and ATPases Research (4 papers). The work is most often cited by research in Clinical Biochemistry (303 citations), Molecular Biology (1.9k citations) and Aging (40 citations). Paweł Golik has collaborated with scholars based in Poland, France and United States. Frequent co-authors include Douglas C. Wallace, R. I. Sukernik, Michael D. Brown, Kirk A. Easley, Martin Brandon, Antonel Olckers, Andrew G. Clark, Eduardo Ruiz‐Pesini, Piotr P. Stępień and Dan Mishmar. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.